Literature DB >> 7816634

An AP1 binding site upstream of the kappa immunoglobulin intron enhancer binds inducible factors and contributes to expression.

J T Schanke1, A Marcuzzi, R P Podzorski, B Van Ness.   

Abstract

Expression of the kappa immunoglobulin light chain gene requires developmental- and tissue-specific regulation by trans-acting factors which interact with two distinct enhancer elements. A new protein-DNA interaction has been identified upstream of the intron enhancer, within the matrix-associated region of the J-C intron. The binding activity is greatly inducible in pre-B cells by bacterial lipopolysaccharide and interleukin-1 but specific complexes are found at all stages of B cell development tested. The footprinted binding site is homologous to the consensus AP1 motif. The protein components of this complex are specifically competed by an AP1 consensus motif and were shown by supershift to include c-Jun and c-Fos, suggesting that this binding site is an AP1 motif and that the Jun and Fos families of transcription factors play a role in the regulation of the kappa light chain gene. Mutation of the AP1 motif in the context of the intron enhancer was shown to decrease enhancer-mediated activation of the promoter in both pre-B cells induced with LPS and constitutive expression in mature B cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7816634      PMCID: PMC332092          DOI: 10.1093/nar/22.24.5425

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  29 in total

Review 1.  The inducible transcription activator NF-kappa B: regulation by distinct protein subunits.

Authors:  P A Baeuerle
Journal:  Biochim Biophys Acta       Date:  1991-04-16

2.  Identification of a second inducible DNA-protein interaction in the kappa immunoglobulin enhancer.

Authors:  K Nelms; R Hromas; B Van Ness
Journal:  Nucleic Acids Res       Date:  1990-02-25       Impact factor: 16.971

3.  Transcription factor interactions: selectors of positive or negative regulation from a single DNA element.

Authors:  M I Diamond; J N Miner; S K Yoshinaga; K R Yamamoto
Journal:  Science       Date:  1990-09-14       Impact factor: 47.728

Review 4.  NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control.

Authors:  M J Lenardo; D Baltimore
Journal:  Cell       Date:  1989-07-28       Impact factor: 41.582

5.  Silencing of the expression of the immunoglobulin kappa gene in non-B cells.

Authors:  J W Pierce; A M Gifford; D Baltimore
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

6.  Patterns of nuclear proto-oncogene expression during induced differentiation and proliferation of human B chronic lymphocytic leukaemia cells.

Authors:  J J Murphy; M Tracz; J D Norton
Journal:  Immunology       Date:  1990-03       Impact factor: 7.397

7.  Transcriptional regulation by Fos and Jun in vitro: interaction among multiple activator and regulatory domains.

Authors:  C Abate; D Luk; T Curran
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

8.  Jun-B gene expression mediated by the surface immunoglobulin receptor of primary B lymphocytes.

Authors:  J F Tilzey; T C Chiles; T L Rothstein
Journal:  Biochem Biophys Res Commun       Date:  1991-02-28       Impact factor: 3.575

9.  c-JUN, JUN B, and JUN D differ in their binding affinities to AP-1 and CRE consensus sequences: effect of FOS proteins.

Authors:  R P Ryseck; R Bravo
Journal:  Oncogene       Date:  1991-04       Impact factor: 9.867

10.  Ubiquitous and lymphocyte-specific factors are involved in the induction of the mouse interleukin 2 gene in T lymphocytes.

Authors:  E Serfling; R Barthelmäs; I Pfeuffer; B Schenk; S Zarius; R Swoboda; F Mercurio; M Karin
Journal:  EMBO J       Date:  1989-02       Impact factor: 11.598

View more
  8 in total

1.  Activation of c-Jun N-terminal kinase (JNK) signalling in experimentally induced gastric lesions in rats.

Authors:  K Mitsuyama; O Tsuruta; Y Matsui; K Harada; N Tomiyasu; A Suzuki; K Takaki; J Masuda; K Handa; Y Satoh; B L Bennett; A Toyonaga; M Sata
Journal:  Clin Exp Immunol       Date:  2006-01       Impact factor: 4.330

2.  Net-b, a Ras-insensitive factor that forms ternary complexes with serum response factor on the serum response element of the fos promoter.

Authors:  A Giovane; P Sobieszczuk; A Ayadi; S M Maira; B Wasylyk
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

3.  SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase.

Authors:  B L Bennett; D T Sasaki; B W Murray; E C O'Leary; S T Sakata; W Xu; J C Leisten; A Motiwala; S Pierce; Y Satoh; S S Bhagwat; A M Manning; D W Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

4.  Coordinate transcription and V(D)J recombination of the kappa immunoglobulin light-chain locus: NF-kappaB-dependent and -independent pathways of activation.

Authors:  D P O'Brien; E M Oltz; B G Van Ness
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

5.  The effect of high dose endotoxin on CYP3A2 expression in the rat.

Authors:  A L Roe; G Warren; G Hou; G Howard; S I Shedlofsky; R A Blouin
Journal:  Pharm Res       Date:  1998-10       Impact factor: 4.200

6.  Elongation factor 1 alpha1 and genes associated with Usher syndromes are downstream targets of GBX2.

Authors:  David A Roeseler; Shrikesh Sachdev; Desire M Buckley; Trupti Joshi; Doris K Wu; Dong Xu; Mark Hannink; Samuel T Waters
Journal:  PLoS One       Date:  2012-11-08       Impact factor: 3.240

7.  Gbx2 Is Required for the Migration and Survival of a Subpopulation of Trigeminal Cranial Neural Crest Cells.

Authors:  David A Roeseler; Lona Strader; Matthew J Anderson; Samuel T Waters
Journal:  J Dev Biol       Date:  2020-12-11

8.  LMP1-augmented kappa intron enhancer activity contributes to upregulation expression of Ig kappa light chain via NF-kappaB and AP-1 pathways in nasopharyngeal carcinoma cells.

Authors:  HaiDan Liu; Hui Zheng; Zhi Duan; DuoSha Hu; Ming Li; SuFang Liu; ZiJian Li; XiYun Deng; ZhenLian Wang; Min Tang; Ying Shi; Wei Yi; Ya Cao
Journal:  Mol Cancer       Date:  2009-10-27       Impact factor: 27.401

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.